Drug Trial Radar · NCT00870298
Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin
Last checked: Nov 19, 2026Latest source record: Dec 9, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,971
Actual
Start
Aug 2006
Primary completion
Jan 2007
Study completion Jan 2007
Sponsor
- Lead sponsor
- University of PennsylvaniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 27, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine if a computerized stop order will reduce the number of concurrent trimethoprim/sulfamethoxazole and warfarin orders accepted through the inpatient electronic ordering system while a patient is hospitalized.
Conditions
- Prescribers' Drug Orders
Interventions
Trimethoprim/Sulfamethoxazole and WarfarinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduce concomitant orders for warfarin and tmp/smxTime frame: 7 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.